66 related articles for article (PubMed ID: 11192585)
21. The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function.
Mahata SK; Mahata M; Livsey Taylor CV; Taupenot L; Parmer RJ; O'Connor DT
Adv Exp Med Biol; 2000; 482():263-77. PubMed ID: 11192587
[No Abstract] [Full Text] [Related]
22. Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: roles of potassium ion and nitric oxide.
Long Y; Fu CY; Tian XZ; Chen J; Han M; Wang R
Eur J Pharmacol; 2007 Aug; 569(1-2):119-25. PubMed ID: 17560993
[TBL] [Abstract][Full Text] [Related]
23. The N-terminal domain of chromogranin A (CgA1-40) interacts with monolayers of membrane lipids of fungal and mammalian compositions.
Maget-Dana R; Metz-Boutigue MH; Helle KB
Ann N Y Acad Sci; 2002 Oct; 971():352-4. PubMed ID: 12438150
[No Abstract] [Full Text] [Related]
24. Heterogeneity of endothelium-dependent vasodilation in pressurized cerebral and small mesenteric resistance arteries of the rat.
Lagaud GJ; Skarsgard PL; Laher I; van Breemen C
J Pharmacol Exp Ther; 1999 Aug; 290(2):832-9. PubMed ID: 10411599
[TBL] [Abstract][Full Text] [Related]
25. Potassium induced dilation in bovine coronary artery involves both inward rectifier potassium channels and Na+ /K+ ATPase.
Ulusoy HB; Kaya MG
Acta Physiol Hung; 2009 Dec; 96(4):427-36. PubMed ID: 19942549
[TBL] [Abstract][Full Text] [Related]
26. The vasorelaxing effect of CGRP and natriuretic peptides in isolated bovine retinal arteries.
Boussery K; Delaey C; Van de Voorde J
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1420-7. PubMed ID: 15790910
[TBL] [Abstract][Full Text] [Related]
27. 4-aminopyridine-sensitive K+ channels contributes to NaHS-induced membrane hyperpolarization and relaxation in the rat coronary artery.
Cheang WS; Wong WT; Shen B; Lau CW; Tian XY; Tsang SY; Yao X; Chen ZY; Huang Y
Vascul Pharmacol; 2010; 53(3-4):94-8. PubMed ID: 20430111
[TBL] [Abstract][Full Text] [Related]
28. Vasodilator action of calcium antagonists in coronary arteries in vitro.
Kalsner S
J Pharmacol Exp Ther; 1997 May; 281(2):634-42. PubMed ID: 9152367
[TBL] [Abstract][Full Text] [Related]
29. Wave speed in human coronary arteries is not influenced by microvascular vasodilation: implications for wave intensity analysis.
Rolandi MC; De Silva K; Lumley M; Lockie TP; Clapp B; Spaan JA; Perera D; Siebes M
Basic Res Cardiol; 2014 Mar; 109(2):405. PubMed ID: 24515727
[TBL] [Abstract][Full Text] [Related]
30. Effect of ATP-sensitive potassium channel inhibition on coronary metabolic vasodilation in humans.
Farouque HM; Worthley SG; Meredith IT
Arterioscler Thromb Vasc Biol; 2004 May; 24(5):905-10. PubMed ID: 15016638
[TBL] [Abstract][Full Text] [Related]
31. 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteries.
Gauthier KM; Falck JR; Reddy LM; Campbell WB
Pharmacol Res; 2004 Jun; 49(6):515-24. PubMed ID: 15026029
[TBL] [Abstract][Full Text] [Related]
32. Retina evokes biphasic relaxations in retinal artery unrelated to endothelium, K(V), K(ATP), K(Ca) channels and methyl palmitate.
Takir S; Uydeş-Doğan BS; Ozdemir O
Microvasc Res; 2011 May; 81(3):295-302. PubMed ID: 21382382
[TBL] [Abstract][Full Text] [Related]
33. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
Mahata SK; O'Connor DT; Mahata M; Yoo SH; Taupenot L; Wu H; Gill BM; Parmer RJ
J Clin Invest; 1997 Sep; 100(6):1623-33. PubMed ID: 9294131
[TBL] [Abstract][Full Text] [Related]
34. Vasostatins, N-terminal products of chromogranin A, are released from the stimulated calf spleen in vitro.
Liang F; Dillen L; Zhang XY; Coen EP; Hogue-Angeletti R; Claeys M; De Potter WP
Acta Physiol Scand; 1995 Sep; 155(1):23-30. PubMed ID: 8553874
[TBL] [Abstract][Full Text] [Related]
35. Calreticulin, an antithrombotic agent which binds to vitamin K-dependent coagulation factors, stimulates endothelial nitric oxide production, and limits thrombosis in canine coronary arteries.
Kuwabara K; Pinsky DJ; Schmidt AM; Benedict C; Brett J; Ogawa S; Broekman MJ; Marcus AJ; Sciacca RR; Michalak M
J Biol Chem; 1995 Apr; 270(14):8179-87. PubMed ID: 7713923
[TBL] [Abstract][Full Text] [Related]
36. Calreticulin comes of age.
Llewellyn DH; Johnson S; Eggleton P
Trends Cell Biol; 2000 Sep; 10(9):399-402. PubMed ID: 11032461
[No Abstract] [Full Text] [Related]
37. Calreticulin: how many functions in how many cellular compartments? Como, April 1996.
Meldolesi J; Krause KH; Michalak M
Cell Calcium; 1996 Jul; 20(1):83-6. PubMed ID: 8864574
[No Abstract] [Full Text] [Related]
38. [Cardiovascular effects and pathophysiological significance of vasostatins].
Cui XJ; Meng L; Ding WH
Sheng Li Ke Xue Jin Zhan; 2013 Dec; 44(6):429-32. PubMed ID: 24665742
[No Abstract] [Full Text] [Related]
39. Vascular responses to K+ in essential hypertension.
Overbeck HW
Clin Sci (Lond); 1985 Jan; 68(1):101-2. PubMed ID: 3964724
[No Abstract] [Full Text] [Related]
40. Calcium-binding ribonucleoprotein in developing chick embryo brain: its relationship to the ontogenesis of electrical activity.
Iqbal Z; Sharma NC
Int J Neurosci; 1980; 11(3):195-200. PubMed ID: 7440089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
